Johnson & Johnson halts its vaccine trial
The pharmaceutical company paused the late-stage clinical trial of its coronavirus vaccine because of a sick volunteer.
Healthcare, News Now!
Category: Healthcare
How are you feeling today? Keep up to date on news and stories related to healthcare here!
Healthcare, International & Travel, News Now!
Iran has highest daily virus death toll, new patient count
For the second day in a row, Iran announced its highest single-day death toll. — ABC News: Top Stories
Healthcare, News Now!
Coronavirus safety runs into a stubborn barrier: Masculinity
When political leaders suggest basic precautions appear unmanly, men are less likely to follow health and safety advice, experts say. — NYT – Top Stories: Daniel Victor
Healthcare, News Now!, Politics
Trump indicates he no longer has the coronavirus, says he is ‘immune’
President Trump on Sunday indicated that he is no longer testing positive for the coronavirus and claimed that he is now “immune” from the disease as he is set to rejoin the campaign trail soon. — FOX News: Tyler Olson
Healthcare, News Now!
Chris Christie released from hospital after COVID-19 diagnosis
Former New Jersey governor and ABC News contributor Chris Christie said he was released from the hospital on Saturday, one week after his COVID-19 diagnoses. — ABC News: Top Stories
Healthcare, News Now!
Dozens of COVID-19 cases reported at 2 veterans care centers
Dozens of COVID-19 cases have been reported at two veterans care centers in Virginia. — ABC News: Top Stories
Business, Healthcare
B&G Foods issues voluntary allergy alert for a limited number of boxes of Back to Nature® Organic Rosemary & Olive Oil Stoneground Wheat Crackers containing peanut butter cookies
PARSIPPANY, N.J.–(BUSINESS WIRE)–B&G Foods announced today it is voluntarily recalling a very limited number of boxes of a single date code of 6 oz. Back to Nature Organic Rosemary & Olive Oil Stoneground Wheat Crackers, with a “best by” date of APR
Business, Healthcare
LabCorp and HealthEC launch transformative oncology care module
New Software Tool Designed to Help Oncologists Improve Patient Outcomes and Achieve Cost-Saving Goals Available Exclusively through LabCorp and Powered by HealthEC® BURLINGTON, N.C. & EDISON, N.J.–(BUSINESS WIRE)–LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health
Business, Healthcare
Merck announces Week 96 data from Phase 2b study evaluating Islatravir in combination with Doravirine in adults with HIV-1 infection
Treatment With Islatravir and Doravirine Maintained Viral Suppression and No Viral Resistance was Identified Company Also Presenting Phase 1/1b Results for MK-8507, a New Investigational Once-Weekly Oral HIV Agent; Company Advances MK-8507 to Phase 2 KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known